Icono govco
 

Publicación:
Momordica charantia como alternativa terapéutica en la medicina veterinaria

Vista sencilla de ítem
dc.contributor.authorAndrade Kujundzic, Stefanyspa
dc.contributor.authorDuque Suárez, Diegospa
dc.contributor.authorJaramillo Hernández, Dumar Alexanderspa
dc.date.accessioned2012-12-15 00:00:00
dc.date.accessioned2022-06-13T17:37:47Z
dc.date.available2012-12-15 00:00:00
dc.date.available2022-06-13T17:37:47Z
dc.date.issued2012-12-15
dc.description.abstractCon el fin de profundizar en el conocimiento de la fitofarmacología colombiana, particularmente aquella presente en la región de los Llanos Orientales, se eligió la especie Momordica charantia para investigar su composición química y así establecer su utilidad en la Medicina Veterinaria y Zootecnia. Para ello se realizó un análisis fitoquímico preliminar, en él se evaluó la presencia de los principales grupos de metabolitos secundarios asociados con actividad biológica, a saber: alcaloides, flavonoides, triterpenos, glucósidos antracénicos, glucósidos cardiogénicos y saponinas. Se detectó la presencia de alcaloides en la Momordica colectada en la Universidad de los Llanos, estos compuestos son ampliamente conocidos por sus propiedades antidiabéticas. Es notable también la presencia de triterpenos, a los cuales se les atribuyen propiedades antiparasitarias, anticancerígenas, antidiabéticas y antialimentarias. Además, se evidencia la presencia de glucósidos cardiogénicos quienes probablemente presentan actividades antivirales. Los resultados de este trabajo son realmente útiles como primera aproximación a la ampliación del conocimiento químico y a la posible utilidad de las especies presentes en esta zona geográfica de Colombia con características medicinales para la salud humana y animal, que permitan una utilización racional de los recursos naturales de nuestro país, como fuente de desarrollo regional y nacional.spa
dc.description.abstractIn order to further our understanding of phytopharmacology Colombia, particularly those present in the eastern plains region, the species was chosen for further Momordica charantia in chemical composition and thus establish a potential medical utility. This analysis was performed preliminary phytochemical, which evaluated the presence of the main groups of secondary metabolites associated with biological activity, namely: alkaloids, flavonoids, triterpenoids, anthracene glycosides, cardiogenic glycosides and saponins. Was detected the presence of alkaloids in Momordica collected at the University of the Llanos, these compounds are widely known for their antidiabetic properties. It is also remarkable the presence of triterpenes, which are attributed antiparasitic properties, anticancer, anti-HIV, antidiabetic and antifeedant. It also showed the presence of cardiogenic glycosides that may have antiviral activities. The results of this work are really useful as a first approximation to the extension of chemical knowledge and the potential use fullness of the species in this area of Colombia, with medicinal properties to human health and animal-that allow the efficient use of resources country's natural as a source of regional and national development.eng
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.22579/22484817.601
dc.identifier.eissn2248-4817
dc.identifier.urihttps://repositorio.unillanos.edu.co/handle/001/1995
dc.identifier.urlhttps://doi.org/10.22579/22484817.601
dc.language.isospaspa
dc.publisherUniversidad de los Llanosspa
dc.relation.bitstreamhttps://revistas.unillanos.edu.co/index.php/sistemasagroecologicos/article/download/601/655
dc.relation.citationeditionNúm. 2 , Año 2012spa
dc.relation.citationendpage35
dc.relation.citationissue2spa
dc.relation.citationstartpage15
dc.relation.citationvolume3spa
dc.relation.ispartofjournalRevista Sistemas de Producción Agroecológicosspa
dc.relation.referencesAhmed M. S., Calle, J. Reportes manual de laboratorio de farmacognosia y fitoquímica. Departamento de farmacia de la Universidad Nacional de Colombia. Bogotá. 2005.spa
dc.relation.referencesAlmeida. DE. Plantas medicinais brazileiras, Conhecimentos populares e científicos. Hemus Editora Ltda. Sao Paulo. 1993.spa
dc.relation.referencesBrandão, M.G., Zanetti, N., Oliveira, P., Grael, C.F., Santos, A.P., Monte-Mór L.M. Brazilian medicinal plants described by 19th century European naturalists and in the Official Pharmacopoeia. Journal of Ethnopharmacology, 120: 141-48. 2008.spa
dc.relation.referencesChang, C. I., Chen, C. R., Liao, Y. W., Cheng, H. L., Chen, Y. C., Chou, C. H. Cucurbitane-type triterpenoids from Momordica charantia. Journal of Natural Products, 69: 1168-1171. 2006.spa
dc.relation.referencesCheng, H. L., Huang, H. K., Chang, C. I., Tsai, C. P., Chou, C. H. A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase. Journal of Agricultural and Food Chemistry, 56: 6835-6843. 2008.spa
dc.relation.referencesChen, J., Tian, R., Qiu, M., Lu, L., Zheng, Y., Zhang, Z. Trinorcucurbitane and cucurbitane triterpenoids from the roots of Momordica charantia. Phytochemistry, 69, 1043-1048. 2008.spa
dc.relation.referencesCoee, FG., Anderson, GJ. Ethnobotany of the Garifuna of Eastern Nicaragua. Econ Bot, 50 (1): 71-107. 1996. Sch Pharm Univ Connecticut Storrs Ct 06268 USA.spa
dc.relation.referencesGiron, L.M., Freire, V., Alonzo, A., Caceres, A., Ethnobotanical survey of the medicinal flora used by the Caribs of Guatemala. Journal of Ethnopharmacology, 34: 173-187. 1991.spa
dc.relation.referencesHarinantenaina, L., Tanaka, M., Takaoka, S., Oda, M., Mogami, O., Uchida, M., Asakawa, Y., Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chemical and Pharmaceutical Bulletin, 54: 1017-1021. 2006.spa
dc.relation.referencesHusain, J., Tickle, I.J., Wood, S.P., Crystal structure of momordin, a type I ribosome inactivating protein from the seeds of Momordica charantia. FEBS Letters, 342: 154-158. 1994.spa
dc.relation.referencesKhanna, P., Jain, S. C., Panagariya, A., Dixit, V. P. Hypoglycemic activity of polypeptide-p from a plant source. Journal of Natural Products, 44: 648-655. 1981.spa
dc.relation.referencesLans, C., Brown, G. Observations on ethnoveterinary medicines in Trinidad and Tobago. Preventive Veterinary Medicine, 35: 125-142. 1998.spa
dc.relation.referencesLans, C., Turner, N., Brauer, G., Lourenco, G., Georges, K. Ethnoveterinary medicines used for horses in Trinidad and in British Columbia, Canada. Journal of Ethnobiology and Ethnomedicine, 2: 31. 2006.spa
dc.relation.referencesLópez LT. Plantas medicinales con actividad hipoglicemiante. Características, administración y efectos adversos. 25 (5). 2006.spa
dc.relation.referencesLotlikar, M. M., Rajarama Rao, M. R. Pharmacology of a hypoglycaemic principle isolated from fruit of Momordica charantia Linn. Industrial Journal of Pharmacology, 28: 129-133. 1966.spa
dc.relation.referencesMejia, K., Rengifo, E. Plantas medicinales de uso popular en la amazonia peruana. Aeci And IIap. Lima. 1995.spa
dc.relation.referencesMiyahara, Y., Okabe, H., Yamauchi, T. Studies on the constituents of Momordica charantia L. II. Isolation and characterization of minor seed glycosides, Momordicosides C, D, and E. Chemical and Pharmaceutical Bulletin (Tokyo) 29: 1561-1566. 1981.spa
dc.relation.referencesMurakami, T., Emoto, A., Matsuda, H., Yoshikawa, M., Medicinal foodstuffs. Part XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chemical & Pharmaceutical Bulletin (Tokyo), 49: 54-63. 2001.spa
dc.relation.referencesOkabe, H., Miyahara, Y., Yamauchi, T., Miyahara, K., Kawasaki, T. Studies on the constituents of Momordica charantia L. I. Isolation and characterization of momordicosides A and B, glycosides of a pentahydroxy-cucurbitane triterpene. Chemical and Pharmaceutical Bulletin (Tokyo), 28: 2753-2762. 1980.spa
dc.relation.referencesOkabe, H., Miyahara, Y., Yamauchi, T. Studies on the constituents of Momordica charantia L. IV. Characterization of the new cucurbitacin glycosides of the immature fruits. (2). Structures of the bitter glycosides, momordicosides K and L. Chemical and Pharmaceutical Bulletin (Tokyo), 30: 4334-4340. 1982.spa
dc.relation.referencesParkash, A., Ng, T.B., Tso, W.W., Purification and characterization of charantin, a napin-like ribosome-inactivating peptide from bitter gourd (Momordica charantia) seeds. Journal of Peptide Research, 59: 197-202. 2002.spa
dc.relation.referencesRaman, A., Lau, C. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine, 2: 349-362. 1996.spa
dc.relation.referencesSanabria A. Análisis fitoquímico preliminar. Universidad Nacional de Colombia, Facultad de Ciencias, Departamento de Farmacia, Bogotá,1-61. 1983.spa
dc.relation.referencesSatyawati, G.V., Gupta, A.K., Tandon, N., Medicinal plants of India. Indian Council of Medical Research, New Delhi, India, 262 p. 1987.spa
dc.relation.referencesTaylor, L. Technical data report for bitter melon (Momordica charantia). En: Herbal Secrets of the Rainforest. 2nd edition Sage Press. 2002.spa
dc.relation.referencesUSDA. National Nutrient Database for Standard Reference, Release 21. 2008. Disponible en: http://www.nal.usda.gov/fnic/foodcomp/cgi-bin/list_nut_edit.pl/spa
dc.relation.referencesXie, H., Huang, S., Deng, H., Wu, Z., Ji, A., Study on chemical components of Momordica charantia. Zhong Yao Cai. 21: 458-459. 1998.spa
dc.relation.referencesYasuda, M., Iwamoto, M., Okabe, H., Yamauchi, T. Structures of momordicines I, II, and III, the bitter principles in the leaves and vines of Momordica charantia L. Chemical and Pharmaceutical Bulletin (Tokyo), 32: 2044-2047. 1984.spa
dc.relation.referencesYen, G. C., Hwang, L. S. Lycopene from the seeds of ripe bitter melon (Momordica charantia) as a potential red food colorant. II. Storage stability, preparation of powdered lycopene and food applications. Journal of Chinese Agricultural Chemical Society, 23: 151-161. 1985.spa
dc.relation.referencesYesilada, E., Gurbuz, I., Shibata, H. Screening of Turkish antiulcerogenic folk remedies for anti-Helicobacter pylori activity. Journal of Ethnopharmacology 66, 289-293. 1999.spa
dc.relation.referencesYuan, Y.R., He, Y.N., Xiong, J.P., Xia, Z.X. Three-dimensional structure of beta-momorcharin at 2.55 A resolution. Acta Crystallographica Section D-Biological Crystallography, 55: 1144-1151. 1999.spa
dc.relation.referencesZamora M. Medicinal plants used in some rural populations of Oaxaca, Puebla and Veracruz, Mexico. J Ethnopharmacol, 35 (3): 229-257. 1992. Cent Inv Forest Agrop Dis Fed Mexico 04110 México.spa
dc.rightsRevista Sistemas de Producción Agroecológicos - 2012spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.creativecommonsEsta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0spa
dc.sourcehttps://revistas.unillanos.edu.co/index.php/sistemasagroecologicos/article/view/601spa
dc.subjectchickenseng
dc.subjecttreeseng
dc.subjectbiological valueeng
dc.subjectavesspa
dc.subjectárbolesspa
dc.subjectvalor biológicospa
dc.titleMomordica charantia como alternativa terapéutica en la medicina veterinariaspa
dc.title.translatedMomordica charantia as alternative therapy in veterinary medicineeng
dc.typeArtículo de revistaspa
dc.typeJournal Articleeng
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localSección Artículos originalesspa
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREFspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Colecciones

Revista Sistemas de Producción Agroecológicos